Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06215976
PHASE4

The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer

Sponsor: Cairo University

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to evaluate the protective effect of metformin on nephrotoxicity of cisplatin in patients with bladder cancer. The main questions it aims to answer are: * To determine protective effect of metformin on structural and functional kidney injury caused by cisplatin in patients with bladder cancer. * To evaluate the safety of combining cisplatin and metformin on patients with bladder cancer

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

78

Start Date

2023-06-01

Completion Date

2024-12-30

Last Updated

2024-08-20

Healthy Volunteers

No

Interventions

DRUG

Metformin Hydrochloride 500 MG

Metformin 500mg tablets twice daily

Locations (1)

faculty of pharmacy Cairo university

Cairo, Egypt